RxDoctor Payments Data

Eric Cox, DO

Otolaryngology · Grand Rapids, MINPI 1568968956

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Acclarent, Inc at 25.4% of the total. Reporting peaked in 2023 at $1,661 and has fallen 93.8% since, to $103 in 2025.

$4,700in general payments, 2019–2025

Across 58 payments — averaging $81.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$1K
  • Inspire Medical Systems, Inc.$539
  • Regeneron Healthcare Solutions, Inc.$489
  • Aerin Medical Inc.$467
  • GSK$436
  • Integra Lifesciences Corporation$335
  • plus $1K from 8 others

What the payments were for

  • Food & beverage$4,700100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,700 in reported general payments places this provider in the 80th percentile of 257 otolaryngology providers in Michigan.

See all otolaryngology providers in Michigan

Medicare billing

Part B allowed, 2024
$30,125
Medicare patients
95
Services billed
235

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide38$1,455
Azelastine Hcl52$1,158
Fluticasone Propionate45$498
Omeprazole48$444
Levocetirizine Dihydrochloride41$406
Esomeprazole Magnesium12$168
Mupirocin24$156
Famotidine23$104
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen27$49

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →